01 January 2009
Clinical evaluation of busulfan, cladribine and alemtuzumab as reduced intensity conditioning for stem cell transplantation
Kazimierz Halaburda, Bozena Marianska, Krzysztof Warzocha, Barbara Nasilowska-Adamska, Andrzej Szczepinski, Agnieszka Tomaszewska, Jadwiga Sawecka, Joanna SkulimowskaAnn Transplant 2009; 14(2): 7-12 :: ID: 880525
HTML version available soon